Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of a drug discovery technology designed to help in the detection of toxic compounds in food products. The company's technology specializes in the generation of vectors and cells for research with optic imaging that helps in detecting toxic chemical compounds in the environment and food products, enabling clients to have the visualization of molecular events in real time and in all the organs, with high precision.
You’re viewing a free company profile from the PitchBook Platform. To explore Transgenic Operative Products’s full profile, request a free trial.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Early Stage VC | $1.1M | 00.00 | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
---|---|---|---|---|---|---|
Finlombarda Gestioni | Venture Capital | Minority | 000 0000 | 000000 0 |
Name | Title | Board Seat |
Contact Info |
---|---|---|---|
Adriana Maggi | Co-Founder, Board Member & President | ||
Paolo Ciana Ph.D | Co-Founder, Board Member & Vice President |
Name | Representing | Role | Since | Contact Info |
---|---|---|---|---|
Alberto Trombetta Ph.D | Finlombarda Gestioni | Board Member | 000 0000 | |
Carlo Rosa | Self | Board Member | 000 0000 | |
Dario Casati | Self | Board Member | 000 0000 |